Stephane Peluso's most recent trade in Infinity Pharmaceuticals Inc. was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on Aug. 2, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 52,046 (0%) | 0% | - | Common Stock | |
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 0.66 per share. | 02 Aug 2022 | 14,994 | 37,052 (0%) | 0% | 0.7 | 9,932 | Common Stock |
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2022 | 87,027 | 87,027 | - | - | Stock Option(right to buy) | |
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 250,000 | 250,000 | - | - | Stock Options (right to buy) | |
| Infinity Pharmaceuticals Inc. | Stephane Peluso | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 50,000 | 50,000 | - | - | Restricted Stock Unit |